Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Beta-sitosterol has potential health benefits but needs more research to fully understand its effects and improve its use in treatments.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

Licorice has many traditional health benefits, but more research is needed to fully support these claims.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Dutasteride and finasteride affect different cell types differently.

New hair loss treatments have evolved from understanding hair biology and patient needs.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

TGF-β and TNF influence hair follicle cell fate, with TNF being more effective in triggering cell death.

Marine compounds from gorgonians and soft corals show promise for drug development, especially for chronic disorders.

Spironolactone nano-formulations show promise for treating skin disorders, but more research is needed for safety and effectiveness.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Ketoconazole shampoo with finasteride improves hair density in men with hair loss.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

The method effectively measures drug impact on DHT levels in prostate treatments.

Finasteride may improve prostate cancer treatment outcomes.

The conclusion is that skin and hair patterns are formed by a mix of cell activities, molecular signals, and environmental factors.

Activin A and follistatin control when hair cells develop in mouse ears.